News
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...
Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...
Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people ...
Individuals living with chronic hepatitis B will be affected by the cuts and closures as well, with reduced access to essential services for prevention, testing, and treatment, said Chari A.
Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...
GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...
Spontaneous loss of hepatitis B e antigen (HBeAg) followed by seroconversion to anti-HBe usually coincides with normalization of serum alanine aminotransferase (ALT) levels, reduction in HBV DNA ...
An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...
Hepatitis viruses A to E differ in transmission and severity, ranging from foodborne infections to bloodborne risks. We got ...
And if you’re pregnant, you can pass it on to your newborn. Viral hepatitis is an inflammation of your liver that's caused by a virus. The most common ones in the U.S. are hep A, B, and C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results